Validation of the Patient Activation Measure (PAM-13) among individuals with chronic spinal cord injury in mainland China.

IF 1.8 4区医学 Q3 CLINICAL NEUROLOGY

Journal of Spinal Cord Medicine Pub Date : 2024-10-11 DOI:10.1080/10790268.2024.2391594

Hai-Xia Xie, Ai-Rong Wu, Zi-Han Xu, Qi Zhang, Xin-Yu Wang, Hao Yu, Nan Li, Yan Wei, Xiao-Hong Li, Hua Zhai, Feng-Shui Chang

{"title":"Validation of the Patient Activation Measure (PAM-13) among individuals with chronic spinal cord injury in mainland China.","authors":"Hai-Xia Xie, Ai-Rong Wu, Zi-Han Xu, Qi Zhang, Xin-Yu Wang, Hao Yu, Nan Li, Yan Wei, Xiao-Hong Li, Hua Zhai, Feng-Shui Chang","doi":"10.1080/10790268.2024.2391594","DOIUrl":null,"url":null,"abstract":"Context/objective: The 13-item Patient Activation Measure (PAM-13) is the most widely used generic patient activation measure, but spinal cord injury (SCI) related psychometric evaluation of PAM-13 has not been explored globally. This study aimed to assess the validity of the Chinese version of the PAM-13 (PAM-13-C) for individuals with chronic spinal cord injury (CSCI).Design: Cross-sectional study.Setting: Shanghai Sunshine Rehabilitation Center, and some participants were recruited in a WeChat group (the most commonly used social media platform in China).Participants: 284 individuals with spinal cord injury who had lived with the injury for ≥0.5 year.Interventions: NA.Outcome measures: The PAM-13-C, global QoL, seven-item generalized anxiety disorder scale (GAD-7) and nine-item patient health questionnaire (PHQ-9), and General Self-Efficacy Scale (GSES) were used.Results: The mean (SD) PAM-13-C score was 57.4 (16.5). The highest percentage of NA could be observed in item 9 (12.0%). Floor and ceiling effects of the total scores of PAM-13-C were small (0.7% and 6.7%), but a ceiling effect could be observed among all items. Exploratory Factor Analysis supported a one-factor model of the PAM-13-C (CFI = 0.97; RMSEA = 0.07). Construct validity was established through correlation analysis among the PAM-13-C, GAD-7/PHQ-9, global QoL, and GSES. The PAM-13-C demonstrated excellent internal consistency (Cronbach's α = 0.95) and acceptable test-retest reliability.Conclusion: The PAM-13-C is a reliable and valid measure of patient activation for individuals with CSCI in China.","PeriodicalId":50044,"journal":{"name":"Journal of Spinal Cord Medicine","volume":" ","pages":"1-11"},"PeriodicalIF":1.8000,"publicationDate":"2024-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Spinal Cord Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/10790268.2024.2391594","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Context/objective: The 13-item Patient Activation Measure (PAM-13) is the most widely used generic patient activation measure, but spinal cord injury (SCI) related psychometric evaluation of PAM-13 has not been explored globally. This study aimed to assess the validity of the Chinese version of the PAM-13 (PAM-13-C) for individuals with chronic spinal cord injury (CSCI).

Design: Cross-sectional study.

Setting: Shanghai Sunshine Rehabilitation Center, and some participants were recruited in a WeChat group (the most commonly used social media platform in China).

Participants: 284 individuals with spinal cord injury who had lived with the injury for ≥0.5 year.

Interventions: NA.

Outcome measures: The PAM-13-C, global QoL, seven-item generalized anxiety disorder scale (GAD-7) and nine-item patient health questionnaire (PHQ-9), and General Self-Efficacy Scale (GSES) were used.

Results: The mean (SD) PAM-13-C score was 57.4 (16.5). The highest percentage of NA could be observed in item 9 (12.0%). Floor and ceiling effects of the total scores of PAM-13-C were small (0.7% and 6.7%), but a ceiling effect could be observed among all items. Exploratory Factor Analysis supported a one-factor model of the PAM-13-C (CFI = 0.97; RMSEA = 0.07). Construct validity was established through correlation analysis among the PAM-13-C, GAD-7/PHQ-9, global QoL, and GSES. The PAM-13-C demonstrated excellent internal consistency (Cronbach's α = 0.95) and acceptable test-retest reliability.

Conclusion: The PAM-13-C is a reliable and valid measure of patient activation for individuals with CSCI in China.

查看原文本刊更多论文

在中国大陆慢性脊髓损伤患者中验证患者激活测量（PAM-13）。

背景/目的：由13个项目组成的患者活化测量（PAM-13）是最广泛使用的通用患者活化测量方法，但全球尚未对脊髓损伤（SCI）相关的PAM-13进行心理测量学评估。本研究旨在评估 PAM-13 中文版（PAM-13-C）对慢性脊髓损伤（CSCI）患者的有效性：设计：横断面研究：参与者：284名脊髓损伤患者，他们带伤生活≥0.5年：结果测量采用PAM-13-C、总体QoL、七项广泛性焦虑症量表（GAD-7）和九项患者健康问卷（PHQ-9）以及一般自我效能量表（GSES）：PAM-13-C 的平均（标清）得分为 57.4（16.5）分。第 9 项（12.0%）的 NA 百分比最高。PAM-13-C 总分的下限效应和上限效应较小（0.7% 和 6.7%），但在所有项目中均可观察到上限效应。探索性因子分析支持 PAM-13-C 的单因子模型（CFI = 0.97；RMSEA = 0.07）。通过对 PAM-13-C、GAD-7/PHQ-9、全局 QoL 和 GSES 进行相关性分析，建立了结构效度。PAM-13-C显示出良好的内部一致性（Cronbach's α = 0.95）和可接受的测试-再测可靠性：结论：PAM-13-C 是衡量中国 CSCI 患者积极性的可靠而有效的方法。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Spinal Cord Medicine 医学-临床神经学

CiteScore

4.20

自引率

5.90%

发文量

101

审稿时长

6-12 weeks

期刊介绍： For more than three decades, The Journal of Spinal Cord Medicine has reflected the evolution of the field of spinal cord medicine. From its inception as a newsletter for physicians striving to provide the best of care, JSCM has matured into an international journal that serves professionals from all disciplines—medicine, nursing, therapy, engineering, psychology and social work.